CoChat
Sign Up
Cited by 369Wnt/β-catenin signaling in development and cancerAdipose Tissue and MetabolismPeroxisome Proliferator-Activated Receptors

The DOI matches its Crossref record; 52 of the 57 references it cites were found in a registry or an index.

Testosterone Inhibits Adipogenic Differentiation in 3T3-L1 Cells: Nuclear Translocation of Androgen Receptor Complex with β-Catenin and T-Cell Factor 4 May Bypass Canonical Wnt Signaling to Down-Regulate Adipogenic Transcription Factors

Open access
Singh, Rajan, Artaza, Jorge N., Taylor, Wayne E., Braga, Melissa, Yuan, Xin, Gonzalez-Cadavid, Nestor F., Bhasin, Shalender·2006·Endocrinology
DOI 10.1210/en.2004-1649PMC PMC4417624
Open this paper in CoChat — free accountOpen PDF

Abstract

Testosterone supplementation in men decreases fat mass; however, the mechanisms by which it inhibits fat mass are unknown. We hypothesized that testosterone inhibits adipogenic differentiation of preadipocytes by activation of androgen receptor (AR)/β-catenin interaction and subsequent translocation of this complex to the nucleus thereby bypassing canonical Wnt signaling. We tested this hypothesis in 3T3-L1 cells that differentiate to form fat cells in adipogenic medium. We found that these cells express AR and that testosterone and dihydrotestosterone dose-dependently inhibited adipogenic differentiation as analyzed by Oil Red O staining and down-regulation of CCAAT/enhancer binding protein-α and -δ and peroxisome proliferator-activated receptor-γ2 protein and mRNA. These inhibitory effects of androgens were partially blocked by flutamide or bicalutamide. Androgen treatment was associated with nuclear translocation of β-catenin and AR. Immunoprecipitation studies demonstrated association of β-catenin with AR and T-cell factor 4 (TCF4) in the presence of androgens. Transfection of TCF4 cDNA inhibited adipogenic differentiation, whereas a dominant negative TCF4 cDNA construct induced adipogenesis and blocked testosterone’s inhibitory effects. Our gene array analysis indicates that testosterone treatment led to activation of some Wnt target genes. Expression of constitutively activated AR fused with VP-16 did not inhibit the expression of CCAAT/enhancer binding protein-α in the absence of androgens. Testosterone and dihydrotestosterone inhibit adipocyte differentiation in vitro through an AR-mediated nuclear translocation of β-catenin and activation of downstream Wnt signaling. These data provide evidence for a regulatory role for androgens in inhibiting adipogenic differentiation and a mechanistic explanation consistent with the observed reduction in fat mass in men treated with androgens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2004-1649

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

5 of the 57 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Jaubert, 1993, Androgen receptors in hamster white adipocytes and their precursor cells: regional variations and modulation by androgens., Endocrine, 1, 535

Cited by

Sorted by citations

See all 369

Related

See all

Metadata

Authors
Singh, R., Artaza, J. N., Taylor, W. E., Braga, M., Yuan, X., Gonzalez-Cadavid, N. F., & Bhasin, S.
Affiliations
  • Charles R. Drew University of Medicine and Science (US)
  • Beth Israel Deaconess Medical Center (US)
  • Division of Endocrinology, Metabolism, and Molecular Medicine (R.S., J.N.A., W.E.T., M.B., N.F.G.-C., S.B.), Charles R. Drew University of Medicine and Science, Los Angeles, California 90059
  • Boston Medical Center (US)
Corresponding author
Singh, Rajan
ORCID
Venue
Endocrinology
Publisher
The Endocrine Society
Published
2006-01-01
Volume
147
Issue
1
Pages
141-154
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
DOI
10.1210/en.2004-1649
PMC
PMC4417624
OpenAlex
W2064549818
Cited by
369
References
57
Citations by year
2026: 6 · 2025: 14 · 2024: 13 · 2023: 5 · 2022: 14 · 2021: 6 · 2020: 17 · 2019: 7 · 2018: 13 · 2017: 27 · 2016: 9 · 2015: 30 · 2014: 20 · 2013: 29 · 2012: 21
FWCI
6.78
Type
journal article
Language
en
Open access
Locations
  • Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (1p20md000545-01, 5u01dk070431-11)
  • National Institute on Aging (SC1AG033407)
  • National Institute of General Medical Sciences (S06GM068510)
  • National Institute of Diabetes and Digestive and Kidney Diseases (1R01 DK 59627-01, U01-DK-070431, R01DK070534, R01DK059627, 1R01DK70431-01)
  • National Center for Research Resources (G12 RR 03026, G12RR003026)
  • National Institute on Minority Health and Health Disparities (1P20MD000545-02, P20 MD000545)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD041748-0, U54HD041748, R01HD043348)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
testosterone, adipogenesis, androgen receptor, β-catenin, T-cell factor 4, Wnt signaling, 3T3-L1 cells, preadipocytes, C/EBPα, C/EBPδ, PPARγ, nuclear translocation, flutamide, bicalutamide, fat mass, androgen supplementation
MeSH terms
Adipose Tissue, Animals, Cell Differentiation, Cell Nucleus, Gene Expression Regulation, Receptors, Androgen, RNA, Messenger, Testosterone, Transcription Factors, Transcription, Genetic, Signal Transduction, 3T3 Cells, Adipocytes, Reverse Transcriptase Polymerase Chain Reaction, Protein Transport, Wnt Proteins, beta Catenin, Mice, TCF Transcription Factors, Transcription Factor 7-Like 2 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review